ロード中...
Glutamate and dopamine components in schizophrenia
The treatment of schizophrenia for the last half century has been with dopamine (DA) D(2) receptor blockers, implicating a hyperdopamine basis for psychosis. However, a 2007 report found that the glutamate agonist LY404039 was effective in schizophrenia, suggesting a hypoglutamate state for the illn...
保存先:
| 第一著者: | |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Canadian Medical Association
2009
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2647567/ https://ncbi.nlm.nih.gov/pubmed/19270765 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|